Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mayr Martina, Becker Karen, Schulte Nadine, Belle Sebastian, Hofheinz Ralf, Krause Annekatrin, Schmid Roland M, Röcken Christoph, Ebert Matthias P
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2012-12-01
Colecção:BMC Cancer
Assuntos:
Imatinib
PDGF
Gastric cancer
Chemotherapy
Acesso em linha:http://www.biomedcentral.com/1471-2407/12/587
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados